OpenVSafe by OpenVAERS
Search V-safe

SVD-17359-49698

3 vaccinations 1 coded response 33 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
302 / GA
Registered
2021-01-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-20
    Registered in v-safe
  2. 2021-01-20
    Dose 1 — Moderna
  3. 2021-01-20
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-10
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-17
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-18
    Dose 2 — Moderna
  13. 2021-02-18
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  17. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-03-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-01-12
    Dose 3 — Moderna
  29. 2022-01-21
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2022-01-26
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-02-02
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-02-09
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-02-16
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-02-23
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-04-13
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-07-13
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  37. 2023-01-12
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Glucose tolerance impaired, Polycystic ovarian syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  38. 2023-01-12
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  39. 2023-01-13

Vaccinations

DoseDateManufacturerCo-administered
12021-01-20Moderna
22021-02-18Moderna
32022-01-12Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDGlucose tolerance impaired · · ✓
SDPolycystic ovarian syndrome · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…